Little is known about vaccine safety in inborn errors of immunity (IEI) patients during the current vaccination campaign for COVID-19. To better investigate the reactogenicity and adverse event profile after two, three, and four doses of mRNA vaccines, we conducted an observational, multicentric study on 342 PID patients from four Italian Referral Centres.
Safety of mRNA COVID-19 Vaccines in Patients with Inborn Errors of Immunity: an Italian Multicentric Study / Milito, Cinzia; Cinetto, Francesco; Garzi, Giulia; Palladino, Andrea; Puca, Marco; Brambilla, Elena; De Vitis, Camilla; Costanzo, Giulia; Scarpa, Riccardo; Punziano, Alessandra; Lagnese, Gianluca; Del Giacco, Stefano; Spadaro, Giuseppe; Quinti, Isabella; Firinu, Davide. - In: JOURNAL OF CLINICAL IMMUNOLOGY. - ISSN 0271-9142. - (2022), pp. 1-9. [10.1007/s10875-022-01402-6]
Safety of mRNA COVID-19 Vaccines in Patients with Inborn Errors of Immunity: an Italian Multicentric Study
Milito, CinziaPrimo
Conceptualization
;Garzi, Giulia;Palladino, Andrea;Quinti, Isabella;
2022
Abstract
Little is known about vaccine safety in inborn errors of immunity (IEI) patients during the current vaccination campaign for COVID-19. To better investigate the reactogenicity and adverse event profile after two, three, and four doses of mRNA vaccines, we conducted an observational, multicentric study on 342 PID patients from four Italian Referral Centres.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
